CoChat

STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer

Kharma, Budiman, Baba, Tsukasa, Matsumura, Noriomi, Kang, Hyun Sook, Hamanishi, Junzo, Murakami, Ryusuke, McConechy, Melissa M., Leung, Samuel, Yamaguchi, Ken, Hosoe, Yuko, Yoshioka, Yumiko, Murphy, Susan K., Mandai, Masaki, Hunstman, David G., Konishi, Ikuo · 2014 · Cancer Research
Cited by 88

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Recent studies of the interferon-induced transcription factor STAT1 have associated its dysregulation with poor prognosis in some cancers, but its mechanistic contributions are not well defined. In this study, we report that the STAT1 pathway is constitutively upregulated in type II endometrial cancers. STAT1 pathway alteration was especially prominent in serous papillary endometrial cancers (SPEC) that are refractive to therapy. Our results defined a “SPEC signature” as a molecular definition of its malignant features and poor prognosis. Specifically, we found that STAT1 regulated MYC as well as ICAM1, PD-L1, and SMAD7, as well as the capacity for proliferation, adhesion, migration, invasion, and in vivo tumorigenecity in cells with a high SPEC signature. Together, our results define STAT1 as a driver oncogene in SPEC that modulates disease progression. We propose that STAT1 functions as a prosurvival gene in SPEC, in a manner important to tumor progression, and that STAT1 may be a novel target for molecular therapy in this disease. Cancer Res; 74(22); 6519–30. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-0847

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 88

Metadata

Authors
Kharma, B., Baba, T., Matsumura, N., Kang, H. S., Hamanishi, J., Murakami, R., McConechy, M. M., Leung, S., Yamaguchi, K., Hosoe, Y., Yoshioka, Y., Murphy, S. K., Mandai, M., Hunstman, D. G., & Konishi, I.
Venue
Cancer Research
Published
2014-11-13
Volume
74
Issue
22
Pages
6519-6530
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2039370099
Cited by
88
References
1
FWCI
6.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-0847
The paper
Kharma, B., Baba, T., Matsumura, N., Kang, H. S., Hamanishi, J., Murakami, R., McConechy, M. M., Leung, S., Yamaguchi, K., Hosoe, Y., Yoshioka, Y., Murphy, S. K., Mandai, M., Hunstman, D. G., & Konishi, I. (2014). STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-0847

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.